MML Investors Services
VERA icon

MML Investors Services’s Vera Therapeutics VERA Stock Holding History

MML Investors Services’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$393K Buy
9,153
+1,585
+21% +$59.1K ﹤0.01% 2635
2026
Q1 		$304K Buy
+7,568
New +$326K ﹤0.01% 2549

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

MML Investors Services's VERA Position: Q2 2026 in Review

MML Investors Services increased its Vera Therapeutics (VERA) stake by 21% in Q2 2026, buying an estimated $59.1K and bringing the position to 9,153 shares worth $393K. The position accounts for ﹤0.01% of the portfolio, ranked #2635.

MML Investors Services first reported a position in VERA in Q1 2026 and has held it in 2 quarters since. 128 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • MML Investors Services held 9,153 shares of Vera Therapeutics worth $393K as of Q2 2026.
  • MML Investors Services bought 1,585 Vera Therapeutics shares in Q2 2026, an estimated $59.1K.
  • Vera Therapeutics made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #2635 holding.
  • MML Investors Services first reported a position in Vera Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 128 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.